Share 'FDA Pediatric Advisory Committee Unanimously Votes YES — Now Moves to Commissioner'
Today’s Pediatric Advisory Committee Meeting resulted in a unanimous decision from committee members to recommend the use of in-dwelling ports in Sarepta's ESSENCE clinical trial. This is an important step forward for our community, providing the possibility of options for families participating in clinical trials.
Here’s a closer look at the voting: Question 1:
Vote: Use of indwelling centra…
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this